Management of Neurological Complications from Carotid Artery Stent Placement

2004 ◽  
pp. 553-562
Author(s):  
M Wholey ◽  
M Wholey
Keyword(s):  
Carotid Artery ◽  
Stent Placement ◽  
Neurological Complications ◽  
Carotid Artery Stent

Evaluation of Glycoprotein IIb/IIIa Inhibitors in Carotid Angioplasty and Stenting

2003 ◽  
Vol 10 (1) ◽  
pp. 33-41 ◽  
Author(s):  
Michael Henry Wholey ◽  
Mark Henry Wholey ◽  
Gustave Eles ◽  
Boulis Toursakissian ◽  
Steven Bailey ◽  
...  
Keyword(s):  
Carotid Artery ◽  
Stent Placement ◽  
Carotid Stenting ◽  
Neurological Complications ◽  
Bleeding Complications ◽  
Control Group ◽  
Intracranial Hemorrhages ◽  
Primary Endpoints ◽  
Intravenous Heparin ◽  
Angioplasty And Stenting

Purpose: To review the immediate neurological and bleeding complications associated with the use of glycoprotein (GP) IIb/IIIa inhibitors in patients undergoing extracranial carotid artery stent placement. Methods: A retrospective review was performed of 550 patients (321 men; mean age 71.1 years, range 28–91) who underwent carotid artery angioplasty and stent placement. Glycoprotein IIb/IIIa inhibitors were given prophylactically along with heparin to 216 patients, whose outcomes were compared to a control group of 334 patients who received intravenous heparin alone. Primary endpoints were the immediate and 30-day neurological complications, including transient ischemic attacks (TIAs), minor and major strokes, and neurologically-related deaths. The secondary endpoint was any abnormal bleeding. Results: The all stroke/neurological death rate in 216 patients treated with heparin and GP IIb/IIIa inhibitors was 6.0% (13 events) compared 2.4% (8 events) in the 334 patients in the heparin-only control group (p = 0.0430). Two of the 4 neurologically-related deaths in the GP IIb/IIIa inhibitor group resulted from intracranial hemorrhages; there were no intracranial hemorrhages in the heparin-only group. There was 1 episode of extracranial bleeding in the GP IIb/IIIa inhibitor group treated with embolization. The incidences of significant puncture-site bleeding requiring transfusion were similar in the groups. Conclusions: Neurological complications following percutaneous carotid artery interventions have been relatively few. The neurological sequelae in carotid stent patients receiving glycoprotein IIb/IIIa inhibitors were more numerous and consequential, which suggests that the use of GP IIb/IIIa inhibitors in carotid stenting should be discouraged.

Frequency and Consequences of Early In-stent Lesions after Carotid Artery Stent Placement

2009 ◽  
Vol 20 (5) ◽  
pp. 573-579 ◽  
Author(s):  
Lisa M. Jongen ◽  
Jeroen Hendrikse ◽  
Annet Waaijer ◽  
H. Bart van der Worp ◽  
Vanessa J. Leijdekkers ◽  
...  
Keyword(s):  
Carotid Artery ◽  
Stent Placement ◽  
Carotid Artery Stent

A Comparison of Carotid Artery Stent Placement Performed within and outside Clinical Trials in the United States (IN2-1.007)

Neurology ◽  
2012 ◽  
Vol 78 (Meeting Abstracts 1) ◽  
pp. IN2-1.007-IN2-1.007
Author(s):  
H. Hussein ◽  
S. Chaudhry ◽  
R. Khatri ◽  
S. Majidi ◽  
G. Rodriguez ◽  
...  
Keyword(s):  
United States ◽  
Clinical Trials ◽  
Carotid Artery ◽  
Stent Placement ◽  
The United States ◽  
Carotid Artery Stent

Delayed occlusion following carotid artery stent placement

2003 ◽  
Vol 99 (5) ◽  
pp. 933
Author(s):  
Jouji Kokuzawa ◽  
Shinichi Yoshimura ◽  
Yasuhiko Kaku ◽  
Noboru Sakai
Keyword(s):  
Carotid Artery ◽  
Stent Placement ◽  
Carotid Artery Stent

scholarly journals Carotid Artery Stent Placement

2010 ◽  
Vol 3 (5) ◽  
pp. 467-474 ◽  
Author(s):  
Christopher J. White
Keyword(s):  
Carotid Artery ◽  
Stent Placement ◽  
Carotid Artery Stent
Sign in / Sign up

Export Citation Format

Share Document